Richard Herrmann - Researcher Profile

Publications

2 shown

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

David Cunningham , Ian Chau , Deborah Stocken +17 more

Purpose Both gemcitabine (GEM) and fluoropyrimidines are valuable treatment for advanced pancreatic cancer. This open-label study was designed to compare the overall survival (O...

2009 Journal of Clinical Oncology 814 citations

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Richard Herrmann , G. Bodoky , Thomas Ruhstaller +17 more

Purpose This phase III trial compared the efficacy and safety of gemcitabine (Gem) plus capecitabine (GemCap) versus single-agent Gem in advanced/metastatic pancreatic cancer. P...

2007 Journal of Clinical Oncology 588 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,402
Institution: Cancer Research UK

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.